Skip to content

Adherence to Blood Pressure Diaries With Personalized Visuals

Picture This: A Randomized Controlled Pilot Study Investigating Adherence to Blood Pressure Diaries With Personalized Visuals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06189378
Enrollment
20
Registered
2024-01-03
Start date
2023-07-07
Completion date
2023-10-29
Last updated
2024-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurovascular Disorder

Keywords

adherence, blood pressure diary, stroke, TIA

Brief summary

This trial randomizes patients with a neurovascular diagnosis to a type of blood pressure diary for secondary stroke prevention (conventional blood pressure diary or blood pressure diary including patient-provided images). Outcomes include adherence and patient-reported outcomes.

Detailed description

In this prospective trial, the investigators randomized persons with diagnoses of stroke or transitoric ischemic attack into two groups: (i) 10 patients received a personalized blood pressure diary with pictures of their choosing. (ii) 10 patients received a blood pressure diary without photographs. The investigators instructed participants in either group to document their blood pressure at home twice daily over twenty-eight days.

Interventions

OTHERInclusion of patient-provided pictures into blood pressure diaries

Patient-provided pictures with positive meaning were included into blood pressure diaries

OTHERConventional blood pressure diary

Conventional blood pressure diary

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* diagnosis of TIA or stroke (ischemic or hemorrhagic) upon admission.

Exclusion criteria

* Modified Rankin Scale score of ≥4 at inclusion * Inability to provide informed consent * Pre-existing legal guardianship.

Design outcomes

Primary

MeasureTime frameDescription
Adherence28 daysThe primary endpoint was adherence to blood pressure diaries defined as the number of complete blood pressure measurements (maximum of two per day) divided by the maximum number of measures over the study period (28 days, resulting in a maximum total of 56 measurements). Complete entries were defined as diary entries stating date, time and systolic as well as diastolic blood pressure.

Secondary

MeasureTime frameDescription
Blood pressure28 daysMean raw values of systolic and diastolic blood pressure
Precision of documentation of blood pressure28 daysThe proportion of documented values ending with 0 or 5 served to assess the extent of rounding (i.e. the precision of documentation)
36-Item Short Form Health Survey28 daysThe 36-Item Short Form Health Survey is a self-report survey of items on a Likert Scale in 8 domains. It is designed to assess quality of life. The maximum amount of points is 100. More points are better.
Hospital Anxiety and Depression Scale28 daysThe Hospital Anxiety and Depression Scale is a self-report rating scale of 14 items on a Likert scale. It is designed to measure anxiety and depression (7 items for each subscale). The maximum amount of points in each subscale is 21. More points are worse.
Patient Global Impression of Change Scale28 daysThe Patient Global Impression of Change Scale is a self-report rating scale of 1 item on a Likert scale (maximum 7, higher score is better) and 1 item on a scale from 0-10 (higher score is worse). It was applied to assess patient satisfaction.

Other

MeasureTime frameDescription
Exploratory endpoints28 daysExploratory endpoints evolved around patients' perspectives on blood pressure diaries as assessed by an empirical survey (13 questions in each group) conceived for this study. Possible answers were Likert-type scales, yes/no or open commentaries.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026